Dr. Jack Merendino, MD

Bio

Dr. John J. "Jack" Merendino, Sharecare Editorial Advisory Board Member, is a board-certified endocrinologist in Bethesda, MD. He is co-author of the New York Times bestseller, The Best Life Guide to Managing Diabetes and Pre-Diabetes. He runs a busy private practice and does consulting for both private industry and government. He is an Assistant Clinical Professor at the George Washington University School of Medicine and is Chief of the Endocrine Section at Suburban Hospital, Johns Hopkins Medicine.

Education

• BS Magna Cum Laude: Chemistry, Georgetown University

• MD: Yale University School of Medicine

• Internship and Residency:  Brigham and Women's Hospital, Harvard Medical School

• Fellowship: National Institutes of Health

• Board Certification: Endocrinology, Diabetes and Metabolism; Internal Medicine

Specialties:

Affiliation:

  • Assistant Clinical Professor, The George Washington Univesity School of Medicine. Chairman, Endocrine Section, Suburban Hospital, Johns Hopkins Medicine

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, May 23 (HealthDay News) -- Certain statins -- the widely used cholesterol-lowering drugs -- may increase your chances of developing type 2 diabetes, a new study suggests.

    The risk was greatest for patients taking atorvastatin (brand name Lipitor), rosu...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, May 23 (HealthDay News) -- Type 2 diabetes is more aggressive in children than adults, with signs of serious complications seen just a few years after diagnosis, new research finds.

    "Based on the latest results, it seems like type 2 is progressing more rapidly in children," sai...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    WEDNESDAY, May 22 (HealthDay News) -- People with heart failure are more likely to experience poorer health from having a thyroid gland that is even mildly underactive, according to a new study.

    And among black patients, the researchers found an increased risk of death linked to the cond...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    WEDNESDAY, May 22 (HealthDay News) -- Fish oil supplements could help reduce the risk for type 2 diabetes, new research suggests.

    The supplements, also known as omega-3 fatty acids, increase levels of a hormone called adiponectin that's linked to insulin sensitivity, Harvard researchers ...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, May 10 (HealthDay News) -- For people with celiac disease, an accurate diagnosis and proper diet are essential for good health, experts say.

    Celiac disease is an intolerance to the protein gluten, which is found in wheat, barley and rye. When people with celiac disease eat gluten-...Full Article

  • Terrell Boynton
  • Nicole Lester
  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, April 25 (HealthDay News) -- A hormone that could lead to more effective diabetes treatment has been identified by researchers.

    The hormone, called betatrophin, causes mice to produce insulin-secreting pancreatic beta cells at up to 30 times the normal rate. But it only produces...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, April 25 (HealthDay News) -- Drinking just one 12-ounce sugar-sweetened soft drink a day can increase the risk of developing type 2 diabetes by up to 22 percent, a European study contends.

    The finding is based on an analysis of data collected from more than 28,000 people in Denm...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, April 12 (HealthDay News) -- Researchers have pinpointed a genetic mutation that is strongly associated with an increased risk of death in people with thyroid cancer.

    The investigators followed more than 1,800 patients after their initial treatment for papillary thyroid cancer, wh...Full Article

  • Lejla Jusufi
    Lejla Jusufi is now following Jack Merendino, MD
  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    MONDAY, April 1 (HealthDay News) -- Invokana (canaglifozin) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes, which affects about 24 million Americans.

    The drug is among a new class of medications called sodium-glucose co-transporter 2 inhibitors. It wor...Full Article

  • Stephanie Ostrander
  • Laurie  Herr
    Laurie Herr is now following Jack Merendino, MD
  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    TUESDAY, March 26 (HealthDay News) -- A simple breath test may be able to tell if you are overweight or will be in the future, a new study suggests.

    According to the findings, results from a standard breath test used to assess bacterial overgrowth in the gut can also tell doctors if you h...Full Article